Hosted on MSN16d
Promising New Radiopharmaceutical Shows Breakthrough Potential in Cancer Treatment
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its ...
Medscape17d
When to Use Anthracyclines in Early Breast Cancer
Chen and her colleagues analyzed data on patients from the TAILORx trial who received a taxane plus cyclophosphamide chemotherapy (TC) or an anthracycline-taxane combination (T-AC), including ...